FDA Brief

Warning letters Drugs

FDA warning letter to

Tropicosmeticos SA de CV

High riskIssued Aug 10, 2021Posted Aug 17, 2021Center for Drug Evaluation and Research

FDA found Tropicosmeticos SA de CV’s Britz hand sanitizer labeled 70% ethanol contained 0% ethanol and >50% methanol.

What happened

FDA tested a batch of Britz HAND SANITIZER that was detained and refused admission at the U.S. border after an import attempt. The product was labeled as made at Tropicosmeticos SA de CV and to contain 70% ethanol, but FDA found 0% ethanol and more than 50% methanol. FDA held a July 1, 2020 teleconference with the firm and its U.S. agent and recommended removing the hand sanitizer from the U.S. market; FDA says the firm did not respond to repeated communications after that.

What FDA found

  1. The hand sanitizer was adulterated because its labeled active ingredient, ethanol, was substituted wholly or partly with methanol.

    FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)
  2. The methanol substitution shows the firm’s quality assurance was not working under current good manufacturing practice (CGMP).

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizer is an unapproved new drug because it was marketed without FDA approval and does not meet the conditions for marketing without an application.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  4. The label is false and misleading because it says the product contains 70% ethanol, but FDA found 0% ethanol and undeclared methanol.

    FD&C Act section 502(a), 21 U.S.C. 352(a)
  5. The label fails to list methanol as an ingredient.

    FD&C Act section 502(e)(1)(A), 21 U.S.C. 352(e)(1)(A)
  6. The product is dangerous to health when used as labeled because methanol can cause serious harm, including blindness or death.

    FD&C Act section 502(j), 21 U.S.C. 352(j)

What FDA wants

FDA asks the firm to respond in writing within 15 working days with a detailed investigation of the methanol substitution, raw-material and batch lists, batch records, a full laboratory assessment and remediation plan, and testing commitments. FDA also strongly recommends a qualified CGMP consultant.

Who should pay attention

  • consumers who use hand sanitizer
  • distributors and retailers selling or importing Britz hand sanitizer
  • companies that buy hand sanitizer from this manufacturer

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk